Cargando…
A Molecularly Detailed Na(V)1.5 Model Reveals a New Class I Antiarrhythmic Target
Antiarrhythmic treatment strategies remain suboptimal due to our inability to predict how drug interactions with ion channels will affect the ability of the tissues to initiate and sustain an arrhythmia. We built a multiscale molecular model of the Na(+) channel domain III (domain III voltage-sensin...
Autores principales: | Moreno, Jonathan D., Zhu, Wandi, Mangold, Kathryn, Chung, Woenho, Silva, Jonathan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834944/ https://www.ncbi.nlm.nih.gov/pubmed/31709321 http://dx.doi.org/10.1016/j.jacbts.2019.06.002 |
Ejemplares similares
-
Modulation of the effects of class Ib antiarrhythmics on cardiac Na(V)1.5-encoded channels by accessory Na(V)β subunits
por: Zhu, Wandi, et al.
Publicado: (2021) -
Inhibitory effects of class I antiarrhythmic agents on Na(+) and Ca(2+) currents of human iPS cell-derived cardiomyocytes
por: Yonemizu, Sayaka, et al.
Publicado: (2019) -
Ranking of binding and nonbinding peptides to MHC class I molecules using inverse folding approach: Implications for vaccine design
por: Singh, Satarudra Prakash, et al.
Publicado: (2008) -
Conservation and divergence in NaChBac and Na(V)1.7 pharmacology reveals novel drug interaction mechanisms
por: Zhu, Wandi, et al.
Publicado: (2020) -
Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities
por: Sharp, Thomas E., et al.
Publicado: (2021)